相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AKI-A Relevant Safety End Point?
Ian E. McCoy et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Measuring Quality in Kidney Care: An Evaluation of Existing Quality Metrics and Approach to Facilitating Improvements in Care Delivery
Mallika L. Mendu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Stopping RAS Inhibitors to Minimize AKI More Harm than Good?
Charles Tomson et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Trends in Quality of Care for Patients with CKD in the United States
Sri Lekha Tummalapalli et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Trends in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use among Those with Impaired Kidney Function in the United States
Daniel P. Murphy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
Rajiv Agarwal et al.
LANCET (2019)
Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease
Yao Qiao et al.
MAYO CLINIC PROCEEDINGS (2019)
Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom
Cecilia Linde et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial
Toshiaki Ohkuma et al.
HYPERTENSION (2019)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
CIRCULATION (2017)
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Ezra A. Amsterdam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Hyperkalemia Associated with Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
Marsha A. Raebel
CARDIOVASCULAR THERAPEUTICS (2012)
Major Barriers against Renin-Angiotensin-Aldosterone System Blocker Use in Chronic Kidney Disease Stages 3-5 in Clinical Practice: A Safety Concern?
Tolga Yildirim et al.
RENAL FAILURE (2012)
Nonsteroidal Anti-Inflammatory Drug Use Among Persons With Chronic Kidney Disease in the United States
Laura Plantinga et al.
ANNALS OF FAMILY MEDICINE (2011)
Prognostic Importance of Early Worsening Renal Function After Initiation of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Cardiac Dysfunction
Jeffrey M. Testani et al.
CIRCULATION-HEART FAILURE (2011)
An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function
Frank A. Holtkamp et al.
KIDNEY INTERNATIONAL (2011)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Hong Kong study using valsartan in IgA nephropathy (HKVIN): A double-blind, randomized, placebo-controlled study
Philip Kam-Tao Li et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease - A meta-analysis of patient-level data
TH Jafar et al.
ANNALS OF INTERNAL MEDICINE (2001)
ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failure
GL Bakris et al.
KIDNEY INTERNATIONAL (2000)
Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine - Is this a cause for concern?
GL Bakris et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
分享论文
